Moderna, Inc. - Common Stock (NQ:MRNA)

190.01 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Why Moderna (MRNA) Stock Is Falling Today

November 03, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an...

Via StockStory

10 Health Care Stocks Whale Activity In Today's Session ↗

November 03, 2025

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

November 03, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Gapping S&P500 stocks in Monday's session ↗

November 03, 2025

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends.

Via Chartmill

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Via Benzinga

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

November 03, 2025

Via ACCESS Newswire

Why Moderna (MRNA) Stock Is Trading Lower Today

October 31, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.5% in the afternoon session after the stock retreated, giving back some of the strong gains from the previous session that were fueled by...

Via StockStory

Exploring the top movers within the S&P500 index during today's session. ↗

October 31, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On? ↗

October 31, 2025

Moderna shares are trading lower Friday afternoon, giving back a portion of gains seen Thursday.

Via Benzinga

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

Topics Artificial Intelligence Supply Chain

AI Revolutionizes Pharma Supply Chains: A New Era of Localized Resilience and Efficiency

October 31, 2025

The pharmaceutical industry is experiencing a profound and immediate transformation as Artificial Intelligence (AI) becomes a strategic imperative for localizing supply chains, fundamentally enhancing...

Via TokenRing AI

Topics Artificial Intelligence Economy Fraud

Discover which S&P500 stocks are making waves on Friday. ↗

October 31, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

Moderna Ignites Biotech Sector with Deal Talk Surge Amidst Broader Healthcare Woes

October 30, 2025

October 30, 2025 – While the broader S&P 500 Healthcare sector navigated a day of mixed to negative performance, a singular beacon of optimism emerged from the biotechnology landscape today as Moderna...

Via MarketMinute

Topics Intellectual Property Stocks

Discover which S&P500 stocks are making waves on Thursday. ↗

October 30, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Moderna Stock Rallies On Reports Of Company Entering Talks With A Drugmaker For A Potential Deal ↗

October 30, 2025

According to a report from Seeking Alpha, citing Stat News, Moderna has held talks with at least one large drugmaker.

Via Stocktwits

Thursday's session: top gainers and losers in the S&P500 index ↗

October 30, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

October 30, 2025

Via Benzinga

Is Moderna Inc Gaining or Losing Market Support? ↗

October 30, 2025

Via Benzinga

1 S&P 500 Stock to Research Further and 2 We Find Risky

October 30, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 28, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.

Via Chartmill

Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers

October 27, 2025

As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence

October 23, 2025

New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares...

Via MarketMinute

Topics Earnings Supply Chain

Moderna Named a Top Employer by Science for Eleventh Consecutive Year

October 23, 2025

Via ACCESS Newswire

Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection ↗

October 23, 2025

Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven and financial guidance.

Via Benzinga

Moderna Topples, Threatening Its 50-Day Line, After A Key Vaccine Bites The Dust ↗

October 23, 2025

The company is scrapping its study in congenital CMV after the vaccine proved just 6% to 23% effective.

Via Investor's Business Daily

Wondering what's happening in today's S&P500 pre-market session? ↗

October 23, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

Via Chartmill

Moderna to Host Investor Event - Analyst Day

October 23, 2025

Via ACCESS Newswire

Moderna Stock Slides After-Hours On CMV Vaccine Failure In Phase 3 Trial — Retail Traders Warn Of ‘Endless’ Cash Burn ↗

October 23, 2025

The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified.

Via Stocktwits

What's going on in today's after hours session: S&P500 movers ↗

October 22, 2025

Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.